Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy COMPASS Pathways (CMPS) stocks in Canada

Learn how to easily invest in COMPASS Pathways stocks.

COMPASS Pathways is a medical care facilities business based in the US. COMPASS Pathways stocks (CMPS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $16.3 – a decrease of 8.94% over the previous week. COMPASS Pathways employs 61 staff and has a market cap (total outstanding stock value) of $747 million.

How to buy shares in COMPASS Pathways

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CMPS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

COMPASS Pathways stock price (NASDAQ:CMPS)

Use our graph to track the performance of CMPS stocks over time.

COMPASS Pathways shares at a glance

Information last updated 2022-01-17.
Latest market close$16.30
52-week range$17.00 - $58.62
50-day moving average $27.72
200-day moving average $32.97
Wall St. target price$82.10
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.68

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy COMPASS Pathways stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

COMPASS Pathways price performance over time

Historical closes compared with the close of $16.3 from 2022-01-20

1 week (2022-01-14) -8.94%
1 month (2021-12-21) -31.91%
3 months (2021-10-21) -53.84%
6 months (2021-07-21) -56.10%
1 year (2021-01-21) -63.72%
2 years (2020-01-17) N/A
3 years (2019-01-17) N/A
5 years (2017-01-17) N/A

COMPASS Pathways financials

Gross profit TTM $0
Return on assets TTM -14.02%
Return on equity TTM -25.53%
Profit margin 0%
Book value $7.32
Market capitalisation $747 million

TTM: trailing 12 months

COMPASS Pathways share dividends

We're not expecting COMPASS Pathways to pay a dividend over the next 12 months.

COMPASS Pathways overview

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site